Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WBP1 pseudogene 1 (abbreviated as WBP1P1) is a pseudogene in the human genome. Pseudogenes are DNA sequences that are similar to functional genes but harbor mutations or sequence defects that render them nonfunctional; they do not produce a functional protein. There is no evidence WBP1P1 encodes any protein product, functions as a receptor, enzyme, transporter, or any typical drug target, nor is it associated with known biological pathways, disease roles, or drug interactions. Pseudogenes are sometimes transcribed into RNA, but these transcripts are usually non-coding. In general, WBP1P1 should not be considered a therapeutic target, and its presence can lead to confusion in genetic studies, for example in PCR amplification or bioinformatic annotation. Key considerations: - The main functional gene in this family is WW domain-binding protein 1 (WBP1), distinct from the pseudogene WBP1P1. - There is no evidence or authoritative source describing WBP1P1 as a protein-coding gene, nor are biological functions or druggability reported for this pseudogene. - Pseudogenes may sometimes have regulatory RNA functions, but no documented function for WBP1P1 is available as of this search. The entry "WBP1 pseudogene 1" appears to have been selected due to similarity to the druggable gene/protein "WW domain-binding protein 1 (WBP1)," but these are not the same—and WBP1P1 is not a bona fide target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WBP1 pseudogene 1 (WBP1P1).